Real-world experience with doxorubicin and olaratumab in soft tissue sarcomas in England and Northern Ireland.

Spyridon GennatasFlorence ChamberlainThomas CarterSusanna SlaterElena CojocaruBeth LambournAnna StansfeldRadha ToddMark VerrillNasim AliRobin L JonesPeter SimmondsNicola KeayHeather McCartySandra StraussVassilios KaravasilisPalma DileoCharlotte Benson

Published in: Clinical sarcoma research (2020)

Our results are in keeping with the phase III study findings: response rate, PFS and OS were similar to those reported in the phase III ANNOUNCE trial.

Keyphrases

phase iii
open label
clinical trial
soft tissue
phase ii
double blind
placebo controlled
drug delivery
randomized controlled trial